Jubilant Pharmova Limited (BOM:530019)
866.05
+1.60 (0.19%)
At close: Aug 17, 2026
Jubilant Pharmova Revenue
Jubilant Pharmova had revenue of 22.29B INR in the quarter ending June 30, 2026, with 17.29% growth. This brings the company's revenue in the last twelve months to 86.08B, up 16.27% year-over-year. In the fiscal year ending March 31, 2026, Jubilant Pharmova had annual revenue of 82.80B with 14.45% growth.
Revenue (ttm)
86.08B
Revenue Growth
+16.27%
P/S Ratio
1.59
Revenue / Employee
15.22M
Employees
5,657
Market Cap
136.92B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 82.80B | 10.45B | 14.45% |
| Mar 31, 2025 | 72.35B | 5.32B | 7.93% |
| Mar 31, 2024 | 67.03B | 4.21B | 6.71% |
| Mar 31, 2023 | 62.82B | 1.52B | 2.47% |
| Mar 31, 2022 | 61.30B | 316.29M | 0.52% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Granules India | 56.32B |
| J. B. Chemicals & Pharmaceuticals | 41.48B |
| Viyash Scientific | 35.76B |
| AstraZeneca Pharma India | 24.32B |
| Caplin Point Laboratories | 22.87B |
| FDC Limited | 21.90B |
| Sanofi India | 18.05B |
| Rubicon Research | 17.54B |
Jubilant Pharmova News
- 7 days ago - Jubilant Pharmova Quarterly report: Q1 2027 - Filings
- 3 months ago - Jubilant Pharmova Transcript: Q4 25/26 - Transcripts
- 3 months ago - Jubilant Pharmova Quarterly report: Q4 2026 - Filings
- 3 months ago - Jubilant Pharmova Slides: Q4 2026 - Filings
- 3 months ago - Jubilant Pharmova Annual report: Q4 2026 - Filings
- 6 months ago - Jubilant Pharmova Quarterly report: Q3 2026 - Filings
- 6 months ago - Jubilant Pharmova Slides: Q3 2026 - Filings
- 7 months ago - Top stocks to watch today, January 7: Titan Company, Mahindra, Godrej Consumer, Jubilant, Biocon and more - Business Upturn